Submitted by Anonymous (not verified) on 29 September 2025 - 15:25
Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised